Preclinical imaging is the process of the visualization in the living organisms for R&D purposes like product improvement. This imaging modalities are in-vivo and non-invasive and it is important to study animal models. Techniques which include preclinical imaging are magnetic resonance imaging, ultrasound, computed tomography are usually used for anatomical imaging, while positron emission tomography, optical imaging and single photon emission computed tomography which are usually for molecular visualizations.
Asia-Pacific Preclinical in-vivo imaging Market: Drivers & Restraints Factors like technological advancements in molecular imaging modalities, rising people awareness, high investments by the private companies, growing acceptance of preclinical imaging as a legitimate drug development tool and favourable government funds are driving for the growth of the market. However, challenges associated with the application of radioisotopes and limited number of skilled professionals are challenging this market.
Asia-Pacific Preclinical in-vivo imaging Market: Segmentation By Modality • Optical imaging o Bioluminescence/fluorescence imaging systems o Standalone fluorescence imaging systems o Optical + X-ray/optical + CT imaging systems • Nuclear imaging o Micro-PET systems (standalone PET, PET/CT, and PET/MRI) o Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) o Tri-modality (PET/SPECT/CT) imaging systems • Micro-MRI • Micro-CT • Micro-ultrasound • Photoacoustic • Magnetic particle imaging systems By Reagent • Optical imaging reagents o Bioluminescent reagents o Fluorescent imaging reagents • Nuclear imaging reagents o Preclinical PET tracers o Preclinical SPECT probes • MRI contrast agents • Ultrasound contrast agents • CT contrast agents By Geography • Asia-Pacific o China o India o Japan o Australia o South Korea
Asia-Pacific Preclinical in-vivo imaging Market: Overview In modality segment, the preclinical optical imaging systems accounted for the largest share in terms of revenue owing to the demand for bioluminescence imaging systems and standalone fluorescence imaging system while preclinical nuclear imaging systems is expected to have the fastest growing rate due to the demand for micro-PET systems and micro-SPECT systems. In reagents segment, the same trend is following as of the modality segment.
In 2017, Asia-Pacific is the fastest growing region witnessed by its CAGR due to the increased government funding for development of pharmaceutical industry, biotech companies are attracting the companies to invest in this region and growing R&D activities by big pharma companies. In 2017, China accounted for the highest revenue while India has the fastest growing rate.
Asia-Pacific Preclinical in-vivo imaging Market: Key Players Major players dominating the Asia-Pacific market are Biospace Lab S.A., Bruker Corporation, Aspect Imaging and LI-COR Biosciences. Other companies include Mediso Ltd., MR Solutions Ltd, PerkinElmer, Inc., MILabs B.V., TriFoil Imaging and FUJIFILM VisualSonics, Inc.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.